Consistent with observations that EZH2 mutated MDS have a very low risk of AML progression [66, 67], no Ezh2−/− or Tet2−/−Ezh2−/− mice developed AML in their experiments [63]. The gene discussed is EZH2; the disease is myelodysplastic syndrome.